New Prostate Cancer Drugs Added to NHF List
The National Health Fund (NHF) has added five new subsidized drugs for prostate cancer treatment to its individual benefits drug list. The drugs are Zoladex, Lucrin, Casodex and Premarin, which have the active ingredients goserelin, leuprolide, flutamide, bicalutamide and conjugated estrogen, which are proven effective in cancer treatment. Marva Lee, Administrative Director of the Jamaica Cancer Society told JIS News...
